-
Loading metrics
Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy
- Janna Krueger,
- Francois Santinon,
- Alexandra Kazanova,
- Mark E. Issa,
- Bruno Larrivee,
- Richard Kremer,
- Catalin Milhalcioiu,
- Christopher E. Rudd
x
- Published: June 28, 2021
- https://doi.org/10.1371/journal.pone.0251731